✦ LIBER ✦

Phase I and Clinical Pharmacology Study of Bevacizumab, Sorafenib, and Low-Dose Cyclophosphamide in Children and Young Adults with Refractory/Recurrent Solid Tumors

✍ Scribed by Navid, F.; Baker, S. D.; McCarville, M. B.; Stewart, C. F.; Billups, C. A.; Wu, J.; Davidoff, A. M.; Spunt, S. L.; Furman, W. L.; McGregor, L. M.; Hu, S.; Panetta, J. C.; Turner, D.; Fofana, D.; Reddick, W. E.; Leung, W.; Santana, V. M.

Book ID: 121686066
Publisher: American Association for Cancer Research
Year: 2012
Tongue: English
Weight: 477 KB
Volume: 19
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-12-1897

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I study of CI-958 in children and

Phase I study of CI-958 in children and adolescents with recurrent solid tumors

✍ Carola A. S. Arndt; Mark D. Krailo; Wen Liu-Mares; Peter M. Anderson; Gregory H. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

BACKGROUND. CI-958 is a synthetic intercalating agent of a new chemical class, the benzopyranoindazoles, with promising preclinical activity. Its mechanism of action is thought to be stabilization of the cleavable complex of DNA with topoisomerase II, as well as DNA helicase blockade. It is thought

Phase I pharmacokinetic and pharmacodyna

Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors

✍ Simonelli, Matteo; Zucali, Paolo A.; Lorenzi, Elena; Rubino, Luca; De Vincenzo, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 585 KB

A study of docetaxel and irinotecan in c

A study of docetaxel and irinotecan in children and young adults with recurrent or refractory Ewing sarcoma family of tumors

✍ Jong Hyung Yoon,Mi Mi Kwon,Hyeon Jin Park,Seog Yun Park,Kun Young Lim… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 806 KB

Phase I and pharmacokinetic study of sor

Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors

✍ Hironobu Minami; Kenji Kawada; Hiromichi Ebi; Koichi Kitagawa; Yon-il Kim; Kazuh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Phase I study of the combination of topo

Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumors

✍ Carlos Rodriguez-Galindo; Kristine R. Crews; Clinton F. Stewart; Wayne Furman; J 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 271 KB

A phase I trial of vorinostat and bortez

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

✍ Jodi A. Muscal; Patrick A. Thompson; Terzah M. Horton; Ashish M. Ingle; Charlott 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB